Darya-Varia Laboratoria Tbk PT
IDX:DVLA

Watchlist Manager
Darya-Varia Laboratoria Tbk PT Logo
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Watchlist
Price: 1 635 IDR 0.31% Market Closed
Market Cap: 1.8T IDR
Have any thoughts about
Darya-Varia Laboratoria Tbk PT?
Write Note

Gross Margin
Darya-Varia Laboratoria Tbk PT

52.7%
Current
52%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52.7%
=
Gross Profit
1.1T
/
Revenue
2.1T

Gross Margin Across Competitors

Country ID
Market Cap 1.8T IDR
Gross Margin
53%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 710.5B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.5B USD
Gross Margin
69%
Country US
Market Cap 251.1B USD
Gross Margin
77%
Country CH
Market Cap 202.7B CHF
Gross Margin
73%
Country CH
Market Cap 183.3B CHF
Gross Margin
75%
Country UK
Market Cap 162.4B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%
No Stocks Found

Darya-Varia Laboratoria Tbk PT
Glance View

Market Cap
1.8T IDR
Industry
Pharmaceuticals

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.

DVLA Intrinsic Value
2 178.44 IDR
Undervaluation 25%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
52.7%
=
Gross Profit
1.1T
/
Revenue
2.1T
What is the Gross Margin of Darya-Varia Laboratoria Tbk PT?

Based on Darya-Varia Laboratoria Tbk PT's most recent financial statements, the company has Gross Margin of 52.7%.